La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Duos Technologies Group a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Duos Technologies Group..

Duos Technologies Group (NASDAQ:DUOT) Azioni, Catena delle Opzioni

DUOS TECHNOLOGIES GROUP INC

Duos Technologies Group

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains that are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

Keybanc analyst Jason Celino maintains Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Overweight and raises the price target from $540 to $610.

News

Price Target

Analyst Ratings

SNPS

Keybanc Maintains Overweight on Synopsys, Raises Price Target to $610

Robin Energy Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBNE#NASDAQ">RBNE</a>) ("Robin Energy" or the "Company"), an international ship-owning company providing energy transportation services globally, announces that it has entered into an agreement, through a wholly owned subsidiary, to acquire a 2015-built 5,000 cbm LPG Carrier vessel from Toro Corp. ("Toro"), a Nasdaq-listed entity controlled by our Chairman and Chief Executive Officer, for a purchase price of $18 million.
The terms of the transaction were approved by the independent and disinterested members of the Boards of Robin Energy and Toro, respectively, following the negotiation and recommendation by special committees of the independent and disinterested directors of the Boards of Robin Energy and Toro.
The acquisition is expected to be concluded by taking delivery of the vessel during the third quarter of 2025 and is subject to the satisfaction of certain customary closing conditions. The Company expects to fund the acquisition with cash on hand.

RBNE

Robin Energy Agrees To Acquire 2015-Built 5,000 Cbm LPG Carrier Vessel From Toro For $18M

NUBURU, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURU#NYSE">BURU</a>) ("NUBURU" or the "Company") is excited to announce that its stockholders have overwhelmingly approved key proposals in support of its financing strategy, a pivotal milestone in the Company's strategic transformation into a leader in defense-tech and operational resilience through its Defense &amp; Security Hub initiative.
This stockholder approval enables NUBURU to advance key strategic objectives, including:
<ul>
<li>Electing Alessandro Zamboni as a Class III director to hold office until the annual meeting of stockholders to be held in 2028 and until his successor is duly elected and qualified.</li>
<li>Increasing authorized share capital and access to equity financings to facilitate strategic growth initiatives.</li>
<li>Ratifying financing agreements to support the working capital needs of the Company, which also provide us with the opportunity to eliminate the market overhang relating to the outstanding preferred stock (which is now classified as a current liability) and extinguish liabilities to key vendors, all of which will strengthen the Company's financial position and make the Company more attractive to investors.</li>
</ul>
"This stockholder vote is a resounding endorsement of the strategic goals of our transformation plan commenced in early January" remarked Alessandro Zamboni, Executive Chairman of NUBURU. "With key components of our ongoing financing structure now in place, we will continue to devote our time and attention to consummating our previously announced strategic investment in Tekne S.p.A., which will be core to our Defense &amp; Security Hub initiative."
The strategic investment in Tekne S.p.A. ("Tekne") remains central to NUBURU's Defense &amp; Security Hub initiative, also by leveraging the Company's high-performance blue laser technology know-how alongside Tekne's product roadmap, which includes its "Tactical Bubble" defense products, currently operational in Italian military exercises, projected to generate revenue exceeding €50 million. The Tactical Bubble enables secure command-and-control networks, countering threats like drones and electromagnetic warfare, and is a key part of Italy's defense modernization.
Management notes that this vote was a pivotal step for NUBURU, allowing for a critical restructuring process and providing the necessary financial flexibility to support the Company's announced business plans. Mr. Zamboni, re-elected for another term as a Director by this vote, has been central to that process. Mr. Zamboni also continues in his role as Executive Chairman of the Company.
The completion of the Tekne strategic investment is contingent, among things, upon obtaining the "Golden Power" authorization as mandated by Italian law. The review process for such authorization is anticipated to conclude by August 5, 2025, unless suspensions are invoked as a result of additional requests for clarification issued by the Italian authorities. Such suspensions would legally extend the review timeline and could consequently defer the expected deadline.

Financing

BURU

NUBURU Stockholders Approve Key Financing Moves To Advance Defense-Tech Strategy And Tekne Investment

Goldman Sachs analyst James Schneider initiates coverage on Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Buy rating and announces Price Target of $620.

Initiation

Goldman Sachs Initiates Coverage On Synopsys with Buy Rating, Announces Price Target of $620

Asset Sales

TORO

Toro Sells LPG Carrier Dream Syrax For $18M

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

KULR

KULR Increases Bitcoin Holdings To 1,021

Goldman Sachs analyst James Schneider initiates coverage on Cadence Design Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>) with a Buy rating and announces Price Target of $380.

CDNS

Goldman Sachs Initiates Coverage On Cadence Design Systems with Buy Rating, Announces Price Target of $380

RCUS

Arcus Biosciences Receives FDA Orphan Drug Designation For Quemliclustat In Pancreatic Cancer

Keybanc analyst Justin Patterson maintains Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a Overweight and raises the price target from $1070 to $1390.

NFLX

Keybanc Maintains Overweight on Netflix, Raises Price Target to $1390

Goldman Sachs analyst James Schneider initiates coverage on Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) with a Buy rating and announces Price Target of $315.

AVGO

Goldman Sachs Initiates Coverage On Broadcom with Buy Rating, Announces Price Target of $315

In a landscape where economic resilience is constantly tested, three key insights from CNBC's &#8220;Halftime Report Final Trades&#8221; offer a glimpse into the shifting dynamics of the industrial and healthcare sectors, as well as the promising <a href="https://www.benzinga.com/topic/ecommerce">potential of e-commerce.</a>
On Wednesday&#8217;s <a href="https://www.cnbc.com/video/2025/07/09/final-trades-wabtec-unitedhealth-and-doordash.html">program</a>, Jim Lebenthal at Cerity Partners said Westinghouse Air Brake Technologies Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAB#NYSE">WAB</a>) is a solid <a href="https://www.benzinga.com/quote/WAB/analyst-ratings">mid-cap industrial</a>.
Supporting his view, BofA Securities analyst Ken Hoexter maintained a Buy rating for Westinghouse Air Brake on Tuesday and raised the price target from $231 to $236.
Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, picked UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), which fell on Wednesday, on the Wall Street Journal article.
UnitedHealth Group is facing renewed legal pressure as shareholders file additional lawsuits, many of which reference a federal investigation into the company&#8217;s Medicare billing practices, as reported by The Wall Street Journal in May.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Joseph M. Terranova, senior managing director for Virtus Investment Partners, said DoorDash, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) has very strong pricing power.
On the earnings front, DoorDash will release second-quarter financial results after the closing bell on Wednesday, Aug. 6. Analysts expect the company to report quarterly earnings at 43 cents per share, versus a year-ago loss of 38 cents per share.
Price Action:
<ul class="wp-block-list">
<li>Westinghouse Air Brake Technologies shares gained 0.6% to close at $213.05 on Wednesday.</li>
<li>UnitedHealth fell 1.6% to close at $302.91 during the session.</li>
<li>DoorDash shares gained 1.9% to close at $246.06 during the session.</li>
</ul>
Check This Out: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46316741/top-3-risk-off-stocks-that-may-rocket-higher-in-q3">Top 3 Risk Off Stocks That May Rocket Higher In Q3</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Media

Trading Ideas

DASH

DoorDash, Westinghouse Air Brake Technologies And A Health Care Stock On CNBC's 'Final Trades'

Biotech

General

JAGX

Jaguar Health Announces Four Dogs Have Now Been Enrolled In Ongoing Field Study Of Canalevia-CA1

WIIM

Genius Group shares are trading higher after the company announced a share buyback approval for up to one million shares.

Goldman Sachs analyst James Schneider initiates coverage on NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) with a Buy rating and announces Price Target of $185.

NVDA

Goldman Sachs Initiates Coverage On NVIDIA with Buy Rating, Announces Price Target of $185

Keybanc analyst Jason Celino maintains Cadence Design Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>) with a Overweight and raises the price target from $340 to $358.

Keybanc Maintains Overweight on Cadence Design Systems, Raises Price Target to $358

BLNK

Blink Charging And Axxeltrova Capital To Pursue £100M Special Purpose Vehicle

ZENA

ZenaTech Creates First Quantum Computing Prototype For AI Drone Solutions

Wells Fargo analyst Tiago Fauth downgrades Verona Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNA#NASDAQ">VRNA</a>) from Overweight to Equal-Weight and lowers the price target from $138 to $107.

Downgrades

VRNA

Wells Fargo Downgrades Verona Pharma to Equal-Weight, Lowers Price Target to $107

Goldman Sachs analyst James Schneider initiates coverage on Applied Mat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) with a Buy rating and announces Price Target of $225.

AMAT

Goldman Sachs Initiates Coverage On Applied Mat with Buy Rating, Announces Price Target of $225

<a href="https://investors.modernatx.com/news/news-details/2025/Moderna-Receives-Full-U-S--FDA-Approval-for-COVID-19-Vaccine-Spikevax-in-Children-Aged-6-Months-Through-11-Years-at-Increased-Risk-for-COVID-19-Disease/default.aspx" title="https://investors.modernatx.com/news/news-details/2025/Moderna-Receives-Full-U-S--FDA-Approval-for-COVID-19-Vaccine-Spikevax-in-Children-Aged-6-Months-Through-11-Years-at-Increased-Risk-for-COVID-19-Disease/default.aspx">https://investors.modernatx.com/news/news-details/2025/Moderna-Receives-Full-U-S--FDA-Approval-for-COVID-19-Vaccine-Spikevax-in-Children-Aged-6-Months-Through-11-Years-at-Increased-Risk-for-COVID-19-Disease/default.aspx</a>

MRNA

Moderna Receives Full FDA Approval for COVID-19 Vaccine, Spikevax, In Children Aged 6 Months Through 11 Years At Increased Risk For COVID-19 Disease

Press Releases

Duos Technologies Group Sets Fourth Quarter and Full Year 2024 Earnings Call for Monday March 31, 2025, at 4:30 PM ET

Earnings

Duos Technologies Group Reports 4th Quarter and FY 2024 Results

APR Energy Delivers 150MW Fast Power to Support Mexico's Grid

Duos Technologies Group Sets First Quarter 2025 Earnings Call for Thursday, May 15, 2025 at 4:30 PM ET

Duos Edge AI Confirms EDC Deployment Goal in 2025

Duos Technologies Group Reports First Quarter 2025 Results

Management

Duos Technologies Appoints Retired Brigadier General Craig Nixon as Chairman of the Board of Directors

Comments

Duos Technologies Group

Duos Technologies Group (DUOT) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO